The Scientist

» immune rejection, culture and disease/medicine

Most Recent

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Speaking of Science: 2016

Speaking of Science: 2016

By | December 19, 2016

Selected quotes from an eventful year

0 Comments

image: Trumping Science: Part II

Trumping Science: Part II

By | December 6, 2016

As Inauguration Day nears, scientists and science advocates are voicing their unease with the Trump Administration’s potential effects on research.

2 Comments

image: Book Excerpt from <em>Redesigning Life</em>

Book Excerpt from Redesigning Life

By | December 1, 2016

In Chapter 8, author John Parrington explores the intersection of precision genome editing and stem cell technologies.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | December 1, 2016

The importance of science innovation, publishing and gender, and more

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: 2016 Top 10 Innovations: Honorable Mentions

2016 Top 10 Innovations: Honorable Mentions

By | December 1, 2016

These runners up to the Top 10 Innovations of 2016 caught our judges' attention.

0 Comments

image: Opinion: The Impact Factor, Re-envisioned

Opinion: The Impact Factor, Re-envisioned

By , , and | November 18, 2016

A combination of the traditional metric and the newer h5 index potentiates the scientific community toward more-balanced evaluation. 

2 Comments

image: More Success Fixing Sickle Cell Gene with CRISPR

More Success Fixing Sickle Cell Gene with CRISPR

By | November 9, 2016

Researchers say they have sufficient in vitro and animal data to apply for human testing.

0 Comments

Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham